A review of research on the intersection between breast cancer and cardiovascular research in the Women’s Health Initiative (WHI)
Sreejata Raychaudhuri(UPMC Hillman Cancer Center), Michael S. Simon(Exponent (United States)), Katherine L. Cook(Wake Forest University), Ana Barac(Inova Fairfax Hospital), Christina M. Dieli‐Conwright(Harvard University), Kerryn W. Reding(University of Washington), Vidhya Nair(Ascension Providence Hospital), Alexi Vasbinder(University of Washington), Pinkal Desai(Cornell University), Richard K. Cheng(University of Washington)
Cited by 11
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589